Abridge, a clinical-AI startup, is launching its Clinician Intelligence Platform in partnership with Nvidia, CEO Dr Shiv Rao announced. The platform transforms clinician-patient conversations into computable workflows that assist throughout the entire visit process. Rao described the technology as an operating system for vertical AI companies targeting regulated domains, emphasising the importance of evaluations in the healthcare sector. The launch represents a significant competitive shift in the clinical AI space.

Abridge launches a patient-centered AI platform to connect care, payment, and clinical evidence. The ambient AI company is moving well beyond note-taking, with NVIDIA building a clinical foundation model to power its next generation of tools June 17, 2026 Abridge built its name on one thing: using AI to listen to doctor-patient conversations and turn them into clinical notes automatically. That was already useful enough to land the company in more than 300 health systems. Now the company wants to do much more. At a keynote event in New York on June 11, Abridge announced what it's calling a patient-centered clinician intelligence platform. The idea is to bring AI into every stage of a clinical encounter, from preparation before the visit to billing and claims after it, and to connect health systems with payers and life sciences organizations through those same clinical workflows. The company also announced a collaboration with NVIDIA to build what both companies describe as the first foundation model built specifically for clinical conversations. Northwestern Medicine, one of Chicago's largest academic health systems, was named as a new enterprise-wide customer. How does it work? Abridge organizes its platform around three stages of the clinical encounter: * Before the visit: The system generates pre-charted notes and patient summaries tailored to the care setting. For hospital rounds, it pulls context from emergency department notes, nursing assessments, labs, and imaging. For outpatient visits, it surfaces a draft history and flags relevant care gaps or chronic conditions before the clinician walks in. * During the visit: Abridge now goes beyond passive transcription. It can suggest discussion topics based on the patient summary and the ongoing conversation. Clinicians can query clinical evidence without leaving the platform. The speech recognition supports more than 28 languages across specialties. * After the visit: The platform generates clinical notes, flowsheets, billing codes, patient summaries, and order drafts. Clinicians can edit outputs using plain language before everything flows into the electronic health record. Abridge integrates with Epic, Oracle Health, and athenahealth. Abridge is also expanding to nurses. The system can capture nurse-patient conversations during inpatient care and turn them into structured EHR documentation, with relevant findings carried forward into the next clinician's pre-visit summary. On the payment side, Abridge is working on real-time claims workflows, aiming to align documentation and billing at the moment care is delivered rather than days or weeks later. The company is partnering with AHIMA, the health information management association, to validate the accuracy and auditability of its coding outputs. For life sciences, Abridge is exploring how clinical context captured during a conversation could help identify patients who may be eligible for clinical trials, including early screening for conditions like Alzheimer's disease where biomarkers can appear years before diagnosis. The NVIDIA collaboration centers on a new foundation model built on the Nemotron open model family, trained on NVIDIA Blackwell infrastructure using de-identified clinical data. Unlike generic large language models adapted for healthcare after the fact, this model is designed to learn clinical reasoning from the ground up across all three training stages. Why does it matter? Physician burnout is a well-documented crisis, and documentation load is one of the biggest drivers. Studies have consistently shown that clinicians spend more time on administrative tasks than on direct patient care. Ambient AI tools like Abridge address that directly, and the evidence from early adopters is starting to look compelling. Reid Health reported that after rolling out Abridge for nurses, its nursing vacancy rate dropped from 18% to 8.6% with no contract staff, and incidental overtime fell 70% on the teams using it. The hospital's chief nursing officer noted that retraining a single nurse costs close to $100,000, which puts the financial case in sharp relief. The payment angle is less developed but potentially more significant. Billions of dollars in care goes unrecognized every year because clinical complexity gets lost between the visit and the claim. If Abridge can ground billing codes and claims in a verified record of what was actually said and done, it could reduce the friction between providers and payers that currently slows down reimbursement and creates costly disputes. The foundation model collaboration with NVIDIA matters because most AI in healthcare today is built on general-purpose models fine-tuned for medical use. A model trained from the start on clinical conversations, across specialties and care settings, could produce more accurate and auditable outputs, which matters enormously in a high-stakes environment where errors have real consequences. The context. Abridge is not the only company in this space. Competitors including Nuance (owned by Microsoft), Suki, and Nabla all offer ambient documentation tools, and Epic has been building its own AI features into its EHR platform. The market is crowded and consolidating fast. What Abridge is trying to do with this announcement is reframe the competitive conversation. Instead of competing on transcription accuracy alone, the company is positioning itself as infrastructure for the entire clinical and financial workflow, which is a much harder category to displace. The clinical decision support additions are also notable. Abridge has signed content agreements with the American Diabetes Association, the American Academy of Family Physicians, the American Heart Association, the New England Journal of Medicine, JAMA, and the Journal of Clinical Oncology, among others. Clinicians using the decision support tools will also be able to claim continuing medical education credit. That kind of ecosystem building takes time to replicate. Abridge says it now supports more than 100 million conversations annually across health systems that collectively serve more than 250 million patients. Those numbers give the company a significant data advantage as it trains the new NVIDIA model, assuming appropriate de-identification and governance processes hold up to scrutiny. That scrutiny, from regulators, privacy advocates, and the health systems themselves, will be one of the more important tests the company faces as it scales.

Abridge unveils new platform, teams up with Lilly and Nvidia. Patients, platforms, Lilly, and Nvidia. Abridge's first keynote had it all. There were enough major announcements to fill an entire issue of DHW, so here's the abridged version of the top stories to come out of NYC. The new platform stole the show. Abridge unveiled "the first AI-native clinician intelligence platform" organized around patients, built for clinicians, and designed to help health systems. * Before the visit: The platform surfaces care gaps and relevant clinical context so clinicians can address what matters during the visit instead of discovering it in retrospective chart reviews. * During the visit: Abridge suggests discussion topics while delivering evidence-based answers to clinical questions from a growing content library that includes new specialty-focused partners like AAFP, AAN, ADA, and ASCO. * After the visit: Abridge generates documentation, flowsheets, patient summaries, orders, and billing codes (soon to be fine-tuned through a new partnership with AHIMA). "The base unit of healthcare is a clinician caring for a patient." As Abridge pushes into new models of care delivery, its platform will provide the connective tissue between the clinical workflows where care actually gets delivered and outside orgs like payers or life sciences firms. * The keynote highlighted some key examples: Cigna was on stage discussing how embedding AI in clinical workflows has the potential to unlock real-time claims adjudication, and Aetna shared how it could help realize the promise of VBC. * More than 300 health systems are already live, including a just-announced rollout at Northwestern Medicine. Eli Lilly is buying into the vision. The pharma giant made a strategic investment in Abridge's next chapter, and even though the keynote was light on details, the move started to add up after seeing one of the new capabilities coming to the platform: clinical trial screening. * By comparing clinical guidance with patient-provider conversations in real-time, Abridge can surface relevant trials directly in the encounter - the moment it matters most. * They didn't mention a check size, but big opportunities attract big investments, and identifying candidates while initiating screening at the point of care sounds huge. Last, but certainly not least, Nvidia. Abridge is teaming up with Nvidia to develop a first-of-its-kind foundation model for clinical conversations that's trained, shaped, and evaluated against real-world conditions. * We'll have to wait until later this year to see it in action, but a little pre-, mid-, and post-training magic with Abridge's de-identified clinical data will apparently help make it the first model that can "reason clinically from its foundation." The Takeaway If the keynote made one thing crystal clear, it's that Abridge's platform doesn't revolve around AI documentation. It revolves around patients, and every new feature is purpose-built to prove it.